Key result
Higher monocyte count was independently associated with subclinical carotid plaque formation in a healthy community population (OR per SD increase 1.4; 95% CI 1.13-1.73; P=0.002).
Why the study?
Is monocyte count an independent risk marker for subclinical carotid atherosclerosis in a healthy community population?
Cross-Sectional (n=1,111)
Is monocyte count an independent risk marker for subclinical carotid atherosclerosis in a healthy community population?
Odds Ratio: 1.4 (95% CI 1.13–1.73)
p-value: p=0.002
Monocyte count may serve as an inexpensive, independent risk marker for subclinical carotid atherosclerosis, outperforming other inflammatory markers like hs-CRP and IL-6.
No takes yet. Share an insight, caveat, or question.
Monocyte count may flag subclinical carotid risk; leaves open prospective validation and clinical utility.
Chapman et al. (2004) conducted a cross-sectional in Subclinical carotid atherosclerosis (n=1,111). Monocyte count was evaluated on Carotid plaque formation (OR 1.4, 95% CI 1.13-1.73, p=0.002). Higher monocyte count was independently associated with subclinical carotid plaque formation in a healthy community population (OR per SD increase 1.4; 95% CI 1.13-1.73; P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: